Found: 16
Select item for more details and to access through your institution.
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/pharmaceutics14071317
- By:
- Publication type:
- Article
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 2313, doi. 10.2147/PPA.S377780
- By:
- Publication type:
- Article
Metastatic Colorectal Carcinoma after Second Progression and the Role of Trifluridine-Tipiracil (TAS-102) in Switzerland.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 237, doi. 10.1159/000506080
- By:
- Publication type:
- Article
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 6, p. 1, doi. 10.1111/jne.13311
- By:
- Publication type:
- Article
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study.
- Published in:
- Cancers, 2024, v. 16, n. 12, p. 2193, doi. 10.3390/cancers16122193
- By:
- Publication type:
- Article
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 316, doi. 10.3390/cancers15010316
- By:
- Publication type:
- Article
(Neo)Adjuvant Treatment of Locally Advanced Esophageal and Gastroesophageal Adenocarcinoma: Special Focus on Sex Differences.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1088, doi. 10.3390/cancers14041088
- By:
- Publication type:
- Article
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group.
- Published in:
- Clinical Colorectal Cancer, 2022, v. 21, n. 3, p. 188, doi. 10.1016/j.clcc.2022.04.001
- By:
- Publication type:
- Article
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2018.01567
- By:
- Publication type:
- Article
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
- Published in:
- British Journal of Cancer, 2021, v. 125, n. 7, p. 911, doi. 10.1038/s41416-021-01474-y
- By:
- Publication type:
- Article
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 6, p. 767, doi. 10.3109/0284186X.2015.1120886
- By:
- Publication type:
- Article
Advances in the Pharmacological Treatment of Gastro-Oesophageal Cancer.
- Published in:
- Drugs & Aging, 2009, v. 26, n. 8, p. 627, doi. 10.2165/11315740-000000000-00000
- By:
- Publication type:
- Article
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2019.01320
- By:
- Publication type:
- Article
Thymostimulin versus placebo for palliativetreatment of locally advanced or metastasisedhepatocellular carcinoma: a phase III clinical trial.
- Published in:
- BMC Cancer, 2010, v. 10, p. 457, doi. 10.1186/1471-2407-10-457
- By:
- Publication type:
- Article